The British government will keep the National Health Service's data contract with Palantir until 2029, declining to trigger an early break clause that would have let it walk away from the controversial US tech giant next spring.

Health minister James Frith told MPs on Monday that the Federated Data Platform contract, the software layer that links patient data across NHS trusts in England, will run until March 2029. The deal, awarded in November 2023 to a Palantir-led group, carries a maximum value of £330 million and was structured as a seven-year term with a three-year initial period ending in March 2027, followed by extension options. Ministers have now taken the two-year option and said the contract ends there.

The decision drew immediate criticism from doctors and MPs. The British Medical Association called it disappointing that ministers would not use the break clause to end the arrangement sooner, while Dame Chi Onwurah, chair of the Commons Science and Technology Committee, questioned the point of a break clause that cannot be exercised. Campaigners said the extension gives the US supplier more time to entrench itself in the health service, and the Office for Statistics Regulation is examining NHS England's claims about the platform's benefits, having already warned it had no evidence for a claim of more than 100,000 extra operations attributed to it.

Frith said the move was about continuity of care for patients benefiting from the existing arrangements, not about the politics of the supplier's executives or customers. Palantir, co-founded by billionaire Peter Thiel, has interests in US defence and contracts with the Israeli military, and has faced sustained criticism over how patient data is used. Former Labour deputy leader Tom Watson, now Palantir's UK senior vice president, welcomed the extension.

Ministers promised a fresh procurement for a new version of the platform, built around interoperability, resilience and common standards, with the formal process beginning in the second half of 2027 and expected to take around 18 months. The first new capability is aimed at maternity services, and Frith said British small firms would be welcome to bid. Palantir itself is not barred from tendering for the replacement contract.

The announcement comes as the government faces pressure from some of its own MPs to cut ties with the company, whose cornerstone NHS contract win in 2023 attracted criticism for a lack of transparency. The US supplier had already won £60 million in NHS contracts without competition during and after the pandemic.